Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models

Airoldi, 2011, Tetracycline prevents Abeta oligomer toxicity through an atypical supramolecular interaction, Org. Biomol. Chem., 9, 463, 10.1039/C0OB00303D Aronson, 1980, Pharmacotherapeutics of the newer tetracyclines, J. Am. Vet. Med. Assoc., 176, 1061 Assar, 2015, A case of variably protease-sensitive prionopathy treated with doxycyclin, J. Neurol. Neurosurg. Psychiatry, 86, 816, 10.1136/jnnp-2014-309871 Baazaoui, 2017, Prevention of amyloid-β and tau pathologies, associated neurodegeneration, and cognitive deficit by early treatment with a neurotrophic compound, J. Alzheimers Dis., 58, 215, 10.3233/JAD-170075 Balducci, 2010, Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein, Proc. Natl. Acad. Sci. U. S. A., 107, 2295, 10.1073/pnas.0911829107 Balducci, 2014, In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches, Curr. Pharm. Des., 20, 2491, 10.2174/13816128113199990497 Balducci, 2017, Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease, Brain Behav. Immun., 60, 188, 10.1016/j.bbi.2016.10.012 Balducci, 2014, Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models, J. Neurosci., 34, 14022, 10.1523/JNEUROSCI.0284-14.2014 Balducci, 2011, The gamma-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice, J. Alzheimers Dis., 24, 799, 10.3233/JAD-2011-101839 Bengoetxea, 2015, Object recognition test for studying cognitive impairments in animal models of Alzheimer’s disease, Front. Biosci. (Schol Ed), 7, 10, 10.2741/s421 Benilova, 2012, The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes, Nat. Neurosci., 15, 349, 10.1038/nn.3028 Callaway, 2012, Alzheimer’s drugs take a new tack, Nature, 489, 13, 10.1038/489013a Coleman, 2003, Synaptic slaughter in Alzheimer’s disease, Neurobiol. Aging, 24, 1023, 10.1016/j.neurobiolaging.2003.09.001 De Luigi, 2008, The efficacy of tetracyclines in peripheral and intracerebral prion infection, PLoS One, 3, e1888, 10.1371/journal.pone.0001888 DeKosky, 1990, Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity, Ann. Neurol., 27, 457, 10.1002/ana.410270502 Diomede, 2010, Tetracycline and its analogues protect Caenorhabditis elegans from beta amyloid-induced toxicity by targeting oligomers, Neurobiol. Dis., 40, 424, 10.1016/j.nbd.2010.07.002 Fluharty, 2013, An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo, J. Biol. Chem., 288, 7857, 10.1074/jbc.M112.423954 Forloni, 2016, Oligomeropathies and pathogenesis of Alzheimer and Parkinson’s diseases, Mov. Disord., 31, 771, 10.1002/mds.26624 Forloni, 2001, Anti-amyloidogenic activity of tetracyclines: studies in vitro, FEBS Lett., 487, 404, 10.1016/S0014-5793(00)02380-2 Forloni, 2002, Tetracyclines affect prion infectivity, Proc. Natl. Acad. Sci. U. S. A., 99, 10849, 10.1073/pnas.162195499 Forloni, 2009, Tetracyclines and prion infectivity, Infect Disord. Drug Targets, 9, 23, 10.2174/1871526510909010023 Frid, 2007, Congo red and protein aggregation in neurodegenerative diseases, Brain Res. Rev., 53, 135, 10.1016/j.brainresrev.2006.08.001 Gandy, 2017, Lifelong management of amyloid-beta metabolism to prevent Alzheimer’s disease, N. Engl. J. Med., 367, 864, 10.1056/NEJMe1207995 Grayson, 2015, Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents, Behav. Brain Res., 285, 176, 10.1016/j.bbr.2014.10.025 Griffin, 2010, Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature, Am. J. Physiol. Cell Physiol., 299, C539, 10.1152/ajpcell.00047.2010 Guerriero, 2017, Neuroinflammation, immune system and Alzheimer disease: searching for the missing link, Aging Clin. Exp. Res., 29, 821, 10.1007/s40520-016-0637-z Haik, 2014, Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial, Lancet Neurol., 13, 150, 10.1016/S1474-4422(13)70307-7 Hammond, 2004, On the delay-dependent involvement of the hippocampus in object recognition memory, Neurobiol. Learn Mem., 82, 26, 10.1016/j.nlm.2004.03.005 Heneka, 2015, Neuroinflammation in Alzheimer’s disease, Lancet Neurol., 14, 388, 10.1016/S1474-4422(15)70016-5 Hong, 2016, Complement and microglia mediate early synapse loss in Alzheimer mouse models, Science, 352, 712, 10.1126/science.aad8373 Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell, 148, 1204, 10.1016/j.cell.2012.02.040 Jankowsky, 2001, Co-expression of multiple transgenes in mouse CNS: a comparison of strategies, Biomol. Eng., 17, 157, 10.1016/S1389-0344(01)00067-3 Kayed, 2013, Molecular mechanisms of amyloid oligomers toxicity, J. Alzheimers Dis., 33, S67 Kincheski, 2017, Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice, Brain Behav. Immun., 64, 140, 10.1016/j.bbi.2017.04.007 Klein, 1995, Tetracyclines, Med. Clin. North Am., 79, 789, 10.1016/S0025-7125(16)30039-6 Krakauer, 2003, Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines, Antimicrob. Agents Chemother., 47, 3630, 10.1128/AAC.47.11.3630-3633.2003 Kumar, 2012, Specific soluble oligomers of amyloid-β peptide undergo replication and form non-fibrillar aggregates in interfacial environments, J. Biol. Chem., 287, 21253, 10.1074/jbc.M112.355156 Lee, 2012, Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation, Neurobiol. Aging, 33, 588, 10.1016/j.neurobiolaging.2010.03.024 Lendel, 2014, A hexameric peptide barrel as building block of amyloid-β protofibrils, Angew. Chem. Int. Ed. Engl., 53, 12756, 10.1002/anie.201406357 Lesné, 2006, A specific amyloid-beta protein assembly in the brain impairs memory, Nature, 440, 352, 10.1038/nature04533 Liddelow, 2017, Neurotoxic reactive astrocytes are induced by activated microglia, Nature, 541, 481, 10.1038/nature21029 Loeb, 2004, A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease, J. Am. Geriatr. Soc., 52, 381, 10.1111/j.1532-5415.2004.52109.x Lue, 1999, Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X Mancini, 2017, Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease, J. Control. Release, 258, 121, 10.1016/j.jconrel.2017.05.013 Mc Donald, 2010, The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia, Brain, 133, 1328, 10.1093/brain/awq065 McLean, 1999, Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease, Ann. Neurol., 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M Molloy, 2013, A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer’s disease: the DARAD trial, Int. J. Geriatr. Psychiatry, 28, 463, 10.1002/gps.3846 Morris, 2013, Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research, Neurobiol. Learn. Mem., 105, 40, 10.1016/j.nlm.2013.07.002 Mucke, 2012, Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction, Cold Spring Harb. Perspect. Med., 2, a006338, 10.1101/cshperspect.a006338 Pocchiari, 2015, Rethinking of doxycycline therapy in Creutzfeldt-Jakob disease, J. Neurol. Neurosurg. Psychiatry, 86, 705, 10.1136/jnnp-2014-310127 Porat, 2006, Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism, Chem. Biol. Drug Des., 67, 27, 10.1111/j.1747-0285.2005.00318.x Rachal Pugh, 2001, The immune system and memory consolidation: a role for the cytokine IL-1beta, Neurosci. Biobehav. Rev., 25, 29, 10.1016/S0149-7634(00)00048-8 Reed, 1997, Impaired recognition memory in patients with lesions limited to the hippocampal formation, Behav. Neurosci., 111, 667, 10.1037/0735-7044.111.4.667 Santos, 2017, Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid beta (Aβ1-40) administration in mice, J. Neuroendocrinol., 29, 1, 10.1111/jne.12476 Sengupta, 2016, The role of amyloid-β oligomers in toxicity, propagation, and immunotherapy, EBioMedicine, 6, 42, 10.1016/j.ebiom.2016.03.035 Squire, 2007, Recognition memory and the medial temporal lobe: a new perspective, Nat. Rev. Neurosci., 8, 872, 10.1038/nrn2154 Stoilova, 2013, A new face for old antibiotics: tetracyclines in treatment of amyloidoses, J. Med. Chem., 56, 5987, 10.1021/jm400161p Sutton, 2006, Dendritic protein synthesis, synaptic plasticity, and memory, Cell, 127, 49, 10.1016/j.cell.2006.09.014 Tagliavini, 2000, Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro, J. Mol. Biol., 300, 1309, 10.1006/jmbi.2000.3840 Tarr, 2011, The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1beta expression, Behav. Brain Res., 217, 481, 10.1016/j.bbr.2010.10.036 Terry, 1991, Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol., 30, 572, 10.1002/ana.410300410 Varges, 2017, Doxycycline in early CJD: a double-blinded randomised phase II and observational study, J. Neurol. Neurosurg. Psychiatry, 88, 119, 10.1136/jnnp-2016-313541 Vasconcelos, 2014, Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment, J. Neuroinflammation, 11, 85, 10.1186/1742-2094-11-85 Wang, 1999, The levels of soluble versus insoluble brain Abeta distinguish Alzheimer’s disease from normal and pathologic aging, Exp. Neurol., 158, 328, 10.1006/exnr.1999.7085 Wolff, 2015, Amyloid β oligomeric species present in the lag phase of amyloid formation, PLoS One, 10, e0127865, 10.1371/journal.pone.0127865 Yrjanheikki, 1998, Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia, Proc. Natl. Acad. Sci. U. S. A., 95, 15769, 10.1073/pnas.95.26.15769